MAPT and Alzheimer disease: In the human AD brain, tau pathology, rather than Aβ pathology, is strongly associated with disease progression, and neuropathological studies show that the burden of tau neurofibrillary tangles, but not Aβ pathology, correlates with the degree of cognitive impairment [33, 34].